Status:
ENROLLING_BY_INVITATION
STN-tTIS Modulates Parkinson Motor Symptoms With and Without Medications
Lead Sponsor:
Ruijin Hospital
Conditions:
Parkinson Disease
Eligibility:
All Genders
50-85 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate the immediate effects of individualized 130 Hz STN-tTIS(Subthalamic Nucleus - transcranial Temporal Interference Stimulation)on motor symptoms in early-t...
Detailed Description
This clinical trial aims to explore whether individualized 130 Hz subthalamic tTIS can improve motor symptoms of PD independently of medication. . Each participant underwent two separate 20-minute ses...
Eligibility Criteria
Inclusion
- MDS diagnosis of primary Parkinson's disease
- Hoehn \& Yahr stage \< 3
- Antiparkinsonian drugs remained unchanged in the past four weeks and dosage remained unchanged during the study
Exclusion
- Presence of neurological disorders that may affect the study (e.g., Traumatic brain injury)
- History of antipsychotics, antidepressants, or dopamine modulators other than PD drugs
- Metal devices in the head or heart (e.g., deep brain stimulators, pacemakers)
- Unstable vital signs
Key Trial Info
Start Date :
April 14 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 18 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06980935
Start Date
April 14 2025
End Date
May 18 2025
Last Update
May 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruijin Hospital
Shanghai, Shanghai Municipality, China